UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026
Bullish on UHT over the next 6–12 months as FFO growth and liquidity support dividend stability.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish on UHT over the next 6–12 months as FFO growth and liquidity support dividend stability.
What happened and why it matters
UHT posted Q2 2026 net income of $5.9M ($0.43 per diluted share), up from $4.5M in the year-ago quarter. Adjusted net income was $5.2M after a $0.724M land-sale gain, with FFO of $12.5M. The credit facility was expanded to $475M (with $109.4M available) and Miller Medical Plaza development with UHS advances, boosting near-term cash-flow visibility despite ongoing Medicaid funding and rate-constrained risk in healthcare tenants.
Stronger near-term FFO growth and expanded debt capacity raise the likelihood of dividend support and potential multiple expansion if tenant risk remains manageable; near-term catalysts include the Miller Medical Plaza progress and a higher borrowing capacity enabling capital deployment.
Q2 2026 net income $5.9M; diluted EPS $0.43, up from $4.5M/$0.32 in 2025.
Adjusted net income $5.2M; land sale gain $0.724M; FFO $12.5M.
Credit facility expanded to $475M; $109.4M available; borrowings $365.6M as of 6/30/2026.
Miller Medical Plaza MOB: 80k sq ft; cost ~$34M; 75% leased to UHS; completion 12/2026.
Q2 dividend $0.75 per share; June 30, 2026 payment.
Category: Earnings. The release centers on quarterly earnings metrics, non-GAAP adjustments, and FFO metrics typical for REITs, plus liquidity/capital structure updates and a strategic development with a major tenant.
More AI-analyzed coverage connected to this story